pilsicainide has been researched along with Death, Sudden, Cardiac in 4 studies
pilsicainide: structure given in first source
pilsicainide : A secondary carboxamide resulting from the formal condensation of the amino group of 2,6-dimethylaniline with the carboxy group of (tetrahydro-1H-pyrrolizin-7a(5H)-yl)acetic acid. It is a sodium channel blocker which is used as an antiarrhythmic drug for the management of atrial tachyarrhythmias in Japan.
Death, Sudden, Cardiac: Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We administered intravenous pilsicainide to 245 consecutive patients with Brugada syndrome (181 patients with spontaneous type 1 ECG, 64 patients with non-type 1 ECG)." | 3.88 | Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome. ( Ito, H; Kawada, S; Miyamoto, M; Morimoto, Y; Morita, H; Nakagawa, K; Nishii, N; Tachibana, M; Ueoka, A; Watanabe, A, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taki, M | 1 |
| Muraji, S | 1 |
| Mori, H | 1 |
| Nabeshima, T | 1 |
| Toda, K | 1 |
| Iwamoto, Y | 1 |
| Masutani, S | 1 |
| Kojima, T | 1 |
| Yoshiba, S | 1 |
| Kobayashi, T | 1 |
| Sumitomo, N | 1 |
| Ueoka, A | 1 |
| Morita, H | 2 |
| Watanabe, A | 1 |
| Morimoto, Y | 1 |
| Kawada, S | 1 |
| Tachibana, M | 1 |
| Miyamoto, M | 1 |
| Nakagawa, K | 1 |
| Nishii, N | 1 |
| Ito, H | 1 |
| Doi, A | 1 |
| Takagi, M | 1 |
| Maeda, K | 1 |
| Tatsumi, H | 1 |
| Shimeno, K | 1 |
| Yoshiyama, M | 1 |
| Takenaka, S | 1 |
| Kusano, KF | 1 |
| Hisamatsu, K | 1 |
| Nagase, S | 1 |
| Nakamura, K | 1 |
| Matsubara, H | 1 |
| Emori, T | 1 |
| Ohe, T | 1 |
4 other studies available for pilsicainide and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Efficacy of a Subcutaneous Implantable Cardioverter Defibrillator in a Child with Early Repolarization Syndrome.
Topics: Anti-Arrhythmia Agents; Child; Death, Sudden, Cardiac; Defibrillators, Implantable; Electrocardiogra | 2021 |
Prognostic Significance of the Sodium Channel Blocker Test in Patients With Brugada Syndrome.
Topics: Administration, Intravenous; Adult; Aged; Brugada Syndrome; Death, Sudden, Cardiac; Electrocardiogra | 2018 |
Conduction delay in right ventricle as a marker for identifying high-risk patients with Brugada syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Coronary Sinus; Death, Sudden, Cardiac; Electrocard | 2010 |
Relatively benign clinical course in asymptomatic patients with brugada-type electrocardiogram without family history of sudden death.
Topics: Adult; Anti-Arrhythmia Agents; Bundle-Branch Block; Death, Sudden, Cardiac; Electrocardiography; Ele | 2001 |